Certified by Founder Lodge
DCVC Bio
United States - Palo Alto, California
INVESTOR
1 Disclosed Funding Rounds $50,000,000
4 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
DCVC Bio is a VC fund investing in early-stage computational biology startups. Advances in genetic sequencing, artificial intelligence and automation are converging to transform existing life
| Company | Date | Round | Raised |
|---|---|---|---|
 Unlearn.AI |
April, 19 ,2022 | Series B | $50,000,000 |
 Ascend Gene & Cell Therapies |
May, 10 ,2023 | Series A | $132,500,000 |
 Solu Therapeutics |
August, 01 ,2023 | Seed | $31,000,000 |
 CH4Global |
August, 30 ,2023 | Series B | $29,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Scorability | $11,000,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
